Your browser doesn't support javascript.
loading
Implementing the WHO Global Initiative for Childhood Cancer in Morocco: Survival study for the six indexed childhood cancers.
Mechita, Nada Bennani; Cherkaoui, Siham; Abousselham, Loubna; Benmiloud, Sarra; Kili, Amina; Kababri, Maria El; Maani, Khadija; Houdzi, Jamila El; Benajiba, Noufissa; Madani, Abdellah; Bennani, Maria; Belakhel, Latefa; Bouffet, Eric; Patte, Catherine; Harif, Mhamed; Youbi, Mohammed; Hessissen, Laila.
Afiliação
  • Mechita NB; Directorate of Epidemiology and Disease Control, Rabat, Morocco.
  • Cherkaoui S; Pediatric Hematology and Oncology Unit, 2O August Hospital Casablanca, Moroccan Society of Pediatric Hematology and Oncology, Casablanca, Morocco.
  • Abousselham L; Directorate of Epidemiology and Disease Control, Rabat, Morocco.
  • Benmiloud S; Pediatric Hematology and Oncology Unit of Fès, Moroccan Society of Pediatric Hematology and Oncology, Fès, Morocco.
  • Kili A; Pediatric Hematology and Oncology Department of Rabat, Moroccan Society of Pediatric Hematology and Oncology, Rabat, Morocco.
  • Kababri ME; Pediatric Hematology and Oncology Department of Rabat, Moroccan Society of Pediatric Hematology and Oncology, Rabat, Morocco.
  • Maani K; Pediatric Hematology and Oncology Unit at Abderrahim El Harouchi Hospital Casablanca, Moroccan Society of Pediatric Hematology and Oncology, Casablanca, Morocco.
  • Houdzi JE; Pediatric Hematology and Oncology Department of Marrakech, Moroccan Society of Pediatric Hematology and Oncology, Marrakech, Morocco.
  • Benajiba N; Pediatric Hematology and Oncology Department of Oujda, Moroccan Society of Pediatric Hematology and Oncology, Oujda, Morocco.
  • Madani A; Pediatric Hematology and Oncology Unit, 2O August Hospital Casablanca, Moroccan Society of Pediatric Hematology and Oncology, Casablanca, Morocco.
  • Bennani M; Lalla Salma Foundation - Cancer Prevention and Treatment, Rabat, Morocco.
  • Belakhel L; Directorate of Epidemiology and Disease Control, Rabat, Morocco.
  • Bouffet E; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Patte C; Francophone African Group of Pediatric Oncology, Gustave Roussy Institut, Villejuif, France.
  • Harif M; University Hospital Center of Tangier, Tangier, Morocco.
  • Youbi M; Directorate of Epidemiology and Disease Control, Rabat, Morocco.
  • Hessissen L; Pediatric Hematology and Oncology Department of Rabat, Moroccan Society of Pediatric Hematology and Oncology, Rabat, Morocco.
Pediatr Blood Cancer ; 69(10): e29788, 2022 10.
Article em En | MEDLINE | ID: mdl-35796382
BACKGROUND: In 2018, the World Health Organization (WHO) launched the Global Initiative for Childhood Cancer (GICC). The goal is to achieve a global survival rate of at least 60% for all children with cancer by 2030. Morocco was designated as a pilot country for this initiative. PROCEDURE: This retrospective study included a cohort of children aged 0-15 years, with one of the six indexed cancers (acute lymphoblastic leukemia [ALL], Burkitt lymphoma [BL], Hodgkin lymphoma, retinoblastoma [RB], Wilms tumor or nephroblastoma, low-grade glioma), diagnosed between January 1, 2017 and December 31, 2019 at the six Moroccan Pediatric Hematology and Oncology units. Patients were followed-up until August 31, 2020. The Kaplan-Meier method was used to estimate survival rates, the log-rank test for comparing survival curves, and the Cox model for identifying prognostic factors. RESULTS: Data on 878 patients were included in the study. The most frequently reported cancer type was ALL (n = 383, 43.6%), followed by Wilms tumor (n = 139, 15.8%) and BL (n = 133, 15%). Most patients were less than 5 years of age (n = 446, 50.9%) and the male/female ratio was 1.46. The 1, 2, and 3-year overall survival rates were 80.1%, 73.6%, and 68.2%, respectively. In a multivariable Cox regression model, care center, cancer type, age group, and distance to the care center were statistically significantly associated to survival. Patients aged 10 years and older and patients living more than 100 km from the care center were more likely to die (respectively, HR = 1.39, p = .045 and HR = 1.44, p = .010). CONCLUSION: The reported results represent the baseline for measuring the impact of GICC implementation in Morocco.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Tumor de Wilms / Neoplasias da Retina / Leucemia-Linfoma Linfoblástico de Células Precursoras / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Tumor de Wilms / Neoplasias da Retina / Leucemia-Linfoma Linfoblástico de Células Precursoras / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article